CIN- L67120MH1995PLC084899

Login

Login

Generate password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID

Cohance Lifesciences Ltd.

NSE : COHANCEEQ BSE : 543064 ISIN CODE : INE03QK01018Industry : Pharmaceuticals

News

  • Cohance Lifesciences has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026 21 Apr 2026 | 17:30 | Dion Global

    As of March 2026 57.49% is owned by Foreign Promoters and 42.51% by Public. Institutional holds 27.38% (Insurance Companies 3.13%) and Non-Institutio...more...

  • Cohance Lifesciences - Clarification With Respect To Volume Movement 13 Apr 2026 | 17:56 | Dion Global

    Clarification with respect to Volume Movementmore...

  • Cohance Lifesciences - Clarification sought from Cohance Lifesciences Ltd 13 Apr 2026 | 16:10 | Dion Global

    The Exchange has sought clarification from Cohance Lifesciences Ltd on April 13 2026 with reference to Movement in Volume. The reply is awaited.more...

  • Cohance Lifesciences - Spurt in Volume 12 Apr 2026 | 23:45 | Dion Global

    Significant increase in volume has been observed in Cohance Lifesciences Limited. The Exchange in order to ensure that investors have latest...more...

  • Cohance Lifesciences - Spurt in Volume 10 Apr 2026 | 19:29 | Dion Global

    Significant increase in volume has been observed in Cohance Lifesciences Limited. The Exchange in order to ensure that investors have latest relevant...more...

  • Cohance Lifesciences - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 02 Apr 2026 | 20:20 | Dion Global

    Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018more...

  • Cohance Lifesciences - Certificate under SEBI (Depositories and Participants) Regulations, 2018 02 Apr 2026 | 20:15 | Dion Global

    Cohance Lifesciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018more...

  • Cohance Lifesciences - Appointment 30 Mar 2026 | 22:11 | Dion Global

    Cohance Lifesciences Limited has informed the Exchange regarding Appointment of Mr Sisir K. Mishra as Company Secretary & Compliance Officer...more...

  • Cohance Lifesciences - Trading Window 27 Mar 2026 | 16:41 | Dion Global

    Cohance Lifesciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulat...more...

  • Cohance Lifesciences - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 13 Mar 2026 | 21:26 | Dion Global

    Grant of Stock Optionsmore...

  • Cohance Lifesciences - Options to purchase securities 13 Mar 2026 | 21:21 | Dion Global

    Cohance Lifesciences Limited has informed the Exchange about Options to purchase securitiesmore...

  • Cohance Lifesciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 06 Mar 2026 | 18:04 | Dion Global

    Investors Meetmore...

  • Cohance Lifesciences - Analysts/Institutional Investor Meet/Con. Call Updates 06 Mar 2026 | 18:03 | Dion Global

    Cohance Lifesciences Limited has informed the Exchange about Schedule of meetmore...

  • Cohance Lifesciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 20 Feb 2026 | 11:00 | Dion Global

    Investors Meetmore...

  • Cohance Lifesciences - Analysts/Institutional Investor Meet/Con. Call Updates 20 Feb 2026 | 11:00 | Dion Global

    Cohance Lifesciences Limited has informed the Exchange about Schedule of meetmore...

  • Cohance Lifesciences - Analysts/Institutional Investor Meet/Con. Call Updates 16 Feb 2026 | 16:49 | Dion Global

    Cohance Lifesciences Limited has informed the Exchange about Transcriptmore...

  • Cohance Lifesciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 16 Feb 2026 | 16:47 | Dion Global

    Con Call Transcriptmore...

  • Cohance Lifesciences - Copy of Newspaper Publication 13 Feb 2026 | 14:43 | Dion Global

    Cohance Lifesciences Limited has informed the Exchange about Copy of Newspaper Publicationmore...

  • Cohance Lifesciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 12 Feb 2026 | 21:37 | Dion Global

    Audio of conference callmore...

  • Cohance Lifesciences - Analysts/Institutional Investor Meet/Con. Call Updates 12 Feb 2026 | 21:34 | Dion Global

    Cohance Lifesciences Limited has informed the Exchange about Link of Recordingmore...

DOW Jones45473.550.16%
Nasdaq21794.160.43%
S&P 5006496.040.22%
Nikkei 22543643.811.45%
Hang Seng25633.910.85%
Shanghai Composite3826.840.38%
Sensex76664.21-1.29%
NSE Index23897.95-1.13%
B500DIVL503607.49-1.30%
BSE 1000 10514.13-1.07%
BSE 100LCTMC8965.34-1.07%
BSE Auto 56681.68-0.78%

Commodity

Gold150212-0.03%
Silver2409890.34%
Copper1261.25209.28%
Crude Oil901840.62%
Lead201.549.93%
Mentha Oil1134.36.27%
Nickel1776131.58%

Currency

USD/INR 94.08(0.26 %)
GBP/INR 126.96(0.09 %)
EUR/INR 110.14(-0.10 %)
JPY/INR 0.59(0.08 %)
CAD/INR 68.68(0.04 %)
HKD/INR 12.01(0.25 %)